Designer Drugs: Hearing Before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-ninth Congress, First Session, on H.R. 2014, H.R. 2977, H.R. 3936, and S. 1437, May 1, 1986 |
Other editions - View all
Common terms and phrases
amended amphetamine appropriate approved Attorney bill California Chairman chemical structure chemists clandestine laboratories Committee compounds conducted Congress controlled substance analogs Controlled Substances Act Cosmetic Act criminal Department of Health designer drug manufacture designer drug problem drug abuse Drug Enforcement Drug Enforcement Administration drug or substance effect emergency scheduling exemption Federal Food fentanyl analogs fetus Florida Food and Drug GRINSPOON HAWKS Health and Human heroin HUGHES human consumption Human Services human subjects illegal illicit drug individuals informed consent Institutional Review Board intended for human intent to distribute investigational law enforcement legislation legitimate research LUNGREN MCCOLLUM MDMA meperidine MPPP MPTP NIDA paragraph Parkinson's disease potential procedures produce programs psychoactive drugs public health regulations research involving scientific Secretary of Health Senator CHILES specific statement studies subpart substance in Schedules substantially similar synthetic Thank therapeutic tion Tocus toxicity trolled substance